These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 2059154)
1. Inhibition of human and rabbit platelet aggregation by chlorophenoxyacid herbicides. Elo HA; Luoma T; Ylitalo P Arch Toxicol; 1991; 65(2):140-4. PubMed ID: 2059154 [TBL] [Abstract][Full Text] [Related]
2. The potentiation of adrenaline-induced in vitro platelet aggregation by ADP, collagen and serotonin and its inhibition by naftopidil and doxazosin in normal human subjects. Alarayyed NA; Graham BR; Prichard BN; Smith CC Br J Clin Pharmacol; 1995 Apr; 39(4):369-74. PubMed ID: 7640142 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of platelet aggregation and thromboxane A2 production by chlorophenoxy acid herbicides. Ylitalo P; Ylihakola M; Elo HA; Koponen HM; Seppälä E; Vapaatalo H Arch Toxicol Suppl; 1991; 14():174-8. PubMed ID: 1839600 [No Abstract] [Full Text] [Related]
4. Inhibitory effects of Atractylodis lanceae rhizoma and Poria on collagen- or thromboxane A2-induced aggregation in rabbit platelets. Nasu Y; Iwashita M; Saito M; Fushiya S; Nakahata N Biol Pharm Bull; 2009 May; 32(5):856-60. PubMed ID: 19420754 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of rabbit platelet aggregation by 1,4-naphthoquinones. Ko FN; Sheu SJ; Liu YM; Huang TF; Teng CM Thromb Res; 1990 Feb; 57(3):453-63. PubMed ID: 2156351 [TBL] [Abstract][Full Text] [Related]
6. The potent inhibition of vapiprost, a novel thromboxane A2 receptor antagonist, on the secondary aggregation and ATP release of human platelets. Horie S; Yamada M; Satoh M; Noritake S; Hiraishi S; Kizaki K; Kurusu O; Nakahara T; Ishii H; Kazama M Biol Pharm Bull; 1997 Jun; 20(6):625-31. PubMed ID: 9212979 [TBL] [Abstract][Full Text] [Related]
7. [Effect of a new thromboxane A2 antagonist, S-145, on platelet aggregation]. Kakushi H; Shike T; Uchida K Nihon Yakurigaku Zasshi; 1989 Mar; 93(3):171-8. PubMed ID: 2731807 [TBL] [Abstract][Full Text] [Related]
8. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets. Watts IS; Wharton KA; White BP; Lumley P Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620 [TBL] [Abstract][Full Text] [Related]
9. Effects of ethanol on pathways of platelet aggregation in vitro. Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075 [TBL] [Abstract][Full Text] [Related]
10. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine. Alarayyed NA; Cooper MB; Prichard BN; Betteridge DJ; Smith CC Br J Clin Pharmacol; 1997 Apr; 43(4):415-20. PubMed ID: 9146854 [TBL] [Abstract][Full Text] [Related]
12. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets. Yin K; Lai PS; Rodriguez A; Spur BW; Wong PY Prostaglandins; 1995 Sep; 50(3):169-78. PubMed ID: 8750213 [TBL] [Abstract][Full Text] [Related]
13. Antiplatelet effects of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e] oxepine-2-carboxylate monohydrate. Karasawa A; Kawakage M; Shirakura S; Higo K; Kubo K; Ohshima E; Obase H Arzneimittelforschung; 1991 Dec; 41(12):1230-6. PubMed ID: 1840011 [TBL] [Abstract][Full Text] [Related]
14. Prostaglandin endoperoxides, thromboxane A2 and adenosine diphosphate in collagen-induced aggregation of rabbit platelets. Lewis GP; Watts IS Br J Pharmacol; 1982 Apr; 75(4):623-31. PubMed ID: 6802211 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet aggregation by some flavonoids. Tzeng SH; Ko WC; Ko FN; Teng CM Thromb Res; 1991 Oct; 64(1):91-100. PubMed ID: 1776142 [TBL] [Abstract][Full Text] [Related]
16. Human recombinant phospholipase A2 inhibits platelet aggregation in vitro and in vivo in rat and guinea pig. Cirino G; Cicala C; Sorrentino R; Sorrentino L; Browning JL; Page CP Eur J Pharmacol; 1994 Feb; 252(2):147-54. PubMed ID: 8157055 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of platelet aggregation in vitro and ex vivo by the new thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid. Seuter F; Perzborn E; Rosentreter U; Böshagen H; Fiedler VB Arzneimittelforschung; 1989 Dec; 39(12):1525-7. PubMed ID: 2624599 [TBL] [Abstract][Full Text] [Related]
18. Dose-responses to inducers and inhibitors of platelet aggregation analysed via a micro-method. Hoylaerts MF; Thys C; Stassen JM; Vermylen J Blood Coagul Fibrinolysis; 1996 Mar; 7(2):187-90. PubMed ID: 8735815 [TBL] [Abstract][Full Text] [Related]
19. [Studies on the inhibitory effect of etafenone hydrochloride on platelet aggregation]. Ujiie A; Komatsu H; Kubota T; Hamano S; Naito J Nihon Yakurigaku Zasshi; 1983 Jun; 81(6):493-8. PubMed ID: 6618341 [TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of G619, a new platelet aggregation inhibitor. Yue TL; Smith EF; Ohlstein EH; Sulpizio A; Slivjak MJ; Rabinovici R; Sellers TS; Lynch KM; Poyser R; Feuerstein G Thromb Res; 1992 May; 66(4):331-47. PubMed ID: 1412200 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]